Built by an experienced and entrepreneurial team.
Prior to Canopy, Kim led Apollo Global Management's $20B high growth Pension Risk Transfer (PRT) business for its insurance unit, Athene. Kim had P&L accountability and oversight of all key functions.
During her tenure, Kim took the business to number one in the market, writing a record $5.5B of new business in 2020.
Kim structured and closed several landmark transactions, including with GE ($2B) and JCPenney ($3.2B). Kim also sat on the board of the women’s Employee Resource Group (ERG) as a Diversity, Equity & Inclusion leader, and as a sponsor of underrepresented talent.
Prior to joining Athene, Kim was one of four founders of $1.2 trillion asset manager Legal and General Group’s US PRT business where she served as Head of Distribution since its 2015 market launch. Kim led sales, marketing, client solutions, business strategy and leadership development growing the business to nearly $4 billion in assets and 50 employees within five years. She previously served as Deputy Head of Distribution for Legal & General Investment Management America business where she worked with corporate pension and insurance clients to implement liability-driven investment and fixed income strategies. Her leadership contributed to nearly $50B of asset growth during her tenure.
Prior to Legal & General, Kim started her career at MBIA Asset Management. Her final role was as a Director where she led the development of pension de-risking strategies and insurance solutions for institutional clients. Prior she helped guide MBIA through the financial crisis, then pivot the business to a retirement solutions platform. Pre-financial crisis she led asset/liability risk management for a $30B bespoke lending business.
Kim holds a Bachelor of Business Administration in public accounting and an honors degree from the Pforzheimer Honors College at Pace University where she graduated magna cum laude. She also holds a Master of Business Administration from Marist College.
From 2010-2018, Joe was a founding team member of Google Shopping Actions, the company’s expansion into verticalized search for retail. He focused on partnership development and management with the country’s largest retailers and fintech providers to implement shared omni-channel distribution strategies in an effort to mitigate Amazon’s market dominance. Joe has an uncanny ability to inspire and motivate partners, clients and team members alike with his cutting-edge ideas and approaches to business development implementing change at large institutions.
Joe has structured first-of-their-kind partnership deals between Google and organizations in both the retail and financial services industries, including negotiating agreements impacting more than $1B of Google e-commerce transaction volume.
Joe left Google in 2018 to pursue entrepreneurial endeavors. He is the co-founder of Subject to Change Wine Company, a globally distributed natural winery based in California. He earned a BA with honors from the Gallatin School at NYU in 2010.
Supported by expert partners, advisors, and collaborators
Lisa Brosseau, ScD, CIHIndustrial Hygiene
Dr. Brosseau is the among the world’s most cited scholars on Respiratory Protection. She is a consultant to the National Institute for Occupational Safety and Health (NIOSH) and the University of Minnesota Center for Infectious Disease Research and Policy (CIDRAP). Past clients have included 3M, Ontario Nurses Union, Manitoba Nurses Union, UAW, National Education Association, OSHA, Moldex, TSI, Inc., and the CDC.
Lisa is certified by the American Board of Industrial Hygiene and Associate Faculty of Occupational Hygiene in the British Occupational Hygiene Society with a focus on respiratory protection, aerosol measurement, filtration performance, and small business health and safety.
Elizabeth Clayborne, MD, MAEmergency Medicine / Bioethics
Dr. Clayborne attended Duke University as an undergraduate where she designed her own major in Medical Ethics and Religion. Prior to medical school she completed a two-year research fellowship at National Institutes of Health in the Social and Behavioral Research Branch of the National Human Genome Research Institute with a research focus on race, ethnicity and genetics. Dr. Clayborne attended to medical school at Case Western Reserve University where she completed a dual MD/MA Bioethics degree in 4 years.
She went on to complete residency in Emergency Medicine at the George Washington University Hospital and served as Chief Resident in her fourth year. Dr. Clayborne is currently a faculty member at the University of Maryland School of Medicine Department of Emergency Medicine with an academic focus on ethics, health policy, end of life care, health disparities and innovation/entrepreneurship. She developed a novel epistaxis device bleedfreeze.com as a resident and in 2015 was awarded the NSF I-Corps grant which helped to launch her company Emergency Medical Innovation, LLC. She is the former Chair of the MedChi Committee on Ethics and Judicial Affairs, serves on the Ethics Committee of the American College of Emergency Physicians and is an active member of the Society of Academic Emergency Medicine, the American Medical Association and the National Medical Association.
Marty GlickInvestor and Advisor
Marty is an accomplished biotech and medical device entrepreneur and executive. He was co-founder and chairman of the board of PEAK Surgical, a medical device company acquired by Medtronic. He also co-founded Eyetech Pharmaceuticals (IPO) and was EVP and CFO of Theravance leading up to their IPO. Marty began his biotech career as a leader in Genentech’s finance organization from 1987-1997.
Marty is a CPA and Chartered Accountant (Ontario, Canada) and holds an MBA in Finance at Kellogg School of Management at Northwestern University.
Marty is in his eighth season with the Golden State Warriors, his sixth as special advisor to ownership. In this capacity, Glick is primarily responsible for advising ownership on major strategic issues including the development of the Chase Center, the team’s state-of-the-art sports and entertainment center and other major strategic initiatives such as the team’s COVID-19 response. He is also a board member for the Warriors Community Foundation.
Prior to assuming his current role in the summer of 2013, Glick served two seasons as chief financial officer for the Warriors, overseeing all financial strategy, planning and accounting for the organization. He is also a minority owner.
Tom Gsell, PhDMaterial Science
Over a span of 36 years, Tom helped grow Pall Corporation into a lead innovator in the field of high-tech filtration. He held R&D leadership positions in increasing responsibility, and appointment to Senior Corporate Vice President in 1996.
Tom’s career led to senior level management responsibilities including global leadership of Materials R&D for both the Pall Industrial and Life Sciences (Medical) divisions. During his tenure Pall’s revenues and profits grew rapidly, fueled by new product innovation made in part possible by the teams under Tom’s purview.
Tom is named as a co-inventor on approximately hundreds granted and published US and International patents, as well as a number of peer reviewed scientific publications.
Narissa Joyner, MDEmergency Medicine
Dr. Joyner is an attending physician in Emergency Medicine at Lenox Hill Hospital in New York City. She completed her training in emergency medicine at Morristown Medical Center Regional Trauma Center in Morristown, NJ. Upon board certification in emergency medicine, she began her independent career with Northwell Health.
Dr. Joyner serves on the Board of Governors for Physician Partners at Northwell Health and is an active member of the American College of Emergency Physicians, the Society of Academic Emergency Medicine, the American Medical Association, the National Medical Association and the Medical Society of the State of New York- Young Physician Section. She is a clinical advisor to Canopy, having served on the front lines of the COVID-19 Pandemic at Lenox Hill Hospital for its duration.
Dr. Joyner provides product development guidance and clinical feedback to Canopy, and has been instrumental in creating a clinical advisory group for Canopy’s product development.LinkedIn Northwell Health profile
Abraar Karan, MD, MPH, DTM&HInfectious Disease / Epidemiology
Dr. Karan is an infectious diseases fellow in the Division of Infectious Diseases and Geographic Medicine with interests in emerging infections, infectious disease epidemiology, and global health equity.
Karan completed his residency in internal medicine at the Brigham and Women's Hospital and Harvard Medical School, and as a graduate of the Doris and Howard Hiatt Residency in Global Health Equity. He earned his MD from the UCLA David Geffen School of Medicine where he served as Student Body President; an MPH from the Harvard T.H. Chan School of Public Health; a Diploma in Tropical Medicine and Hygiene (DTM&H) from the London School of Hygiene and Tropical Medicine; and his undergraduate degree w/ distinction from Yale University in political science, where he was a Yale Journalism Scholar.
From February to October 2020, Dr. Karan worked on COVID19 response for the state of Massachusetts as a medical fellow to Dr. Monica Bharel, MA Commissioner of Public Health. From November to January 2021, he worked as a research consultant to the WHO commissioned Independent Panel for Pandemic Preparedness and Response on Covid-19 epidemiology. He also served as a research assistant for the Harvard College Fall course on Covid-19 and epidemics. Furthermore, Karan was involved in the Biden-Harris campaign's Covid-19 policy writing for school reopenings. Prior to this, Dr. Karan studied epidemic response and emerging infectious diseases, with a focus on rural pathogens, including Ebola. In 2018, Abraar co-founded Longsleeve insect repellent, winner of the 2018 Harvard Business School New Venture Competition and a finalist in the 2019 Harvard President's Challenge, which strives to have a notable impact on curbing transmission of vector-borne epidemic outbreaks. Karan also led the American Medical Association's Journal of Ethics theme issue on pandemic response, published in January 2020; and he is a peer-reviewer for the CDC's Emerging Infectious Diseases Journal.
Dr. Karan's previous work over the past 13 years has included various projects in Latin America (Mexico, Honduras, Nicaragua, Haiti, Dominican Republic), Asia (India, Thailand), and Sub-Saharan Africa (Rwanda, Uganda, Mozambique). In 2011-2012, as a Yale Parker Huang Fellow, Karan conducted an anthropological research study in India exploring sex trafficking and intergenerational sex work in Hyderabad and Delhi. He is also interested in the intersection between medical ethics and global health (particularly neocolonialism). Abraar participated as a medical fellow in Auschwitz studying the history of the Holocaust for the FASPE program in 2016; and led the AMA Journal of Ethics twice (2016-17 on international healthcare systems; 2019-20 on pandemic response).
Since January 2019, Dr. Karan has also been a columnist at the British Medical Journal. Prior to that, he co-edited the book, "Protecting the Health of the Poor", which was published in December 2015. He has authored works in the NEJM, The Lancet, The BMJ, Academic Medicine, Health Affairs, NPR, WaPo, Vox, Los Angeles Times, CNN, Scientific American, Huffpost, Boston Globe, Harvard Business Review, and other major publications. Press coverage has included: NBC, ABC, BBC, PBS, CBS, CNN, MSNBC, Washington Post, New York Times, Bloomberg, Boston Globe, ProPublica, WSJ, TIME, TMZ, Science Friday, Medium, The Verge, Politico, CBC News, MTV News, Democracy Now, NPR, ESPN, The Atlantic, The Hill, Business Insider, Vice, Mother Jones, Boston Magazine, Vox, Healthline, Forbes, Slate, STAT News, Harvard Public Health Magazine (cover story Spring 2020), and others
David NarrowBusiness Advisor
David Narrow is co-founder and CEO of Sonavex Inc., a venture-backed commercial stage medical device company spun-out of Johns Hopkins University, which has raised over $14M. The company develops and commercializes ultrasound products for surgeons, including a technology for detecting post-operative vascular complications.
David previously worked with multinational medical device companies to commercialize their technologies and provide long-term business strategy as a healthcare consultant at Health Advances LLC. Narrow earned his B.S. in Biomedical Engineering with Highest Distinction from the University of Rochester before receiving his Masters from Johns Hopkins University. He was named 30 Under 30 in Healthcare by Forbes in 2016, 40 Under 40 by the Baltimore Business Journal in 2017, and recognized as Baltimore’s Top BioHealth Startup CEO in 2019.
Governor Peter ShumlinGovernment Relations / Public Health
Governor Peter Shumlin served three terms as the 81st governor of the state of Vermont. He was a member of the Vermont House of Representatives from 1990 to 1993, and served as State Senator for the Windham County from 1993 to 2003 and from 2007 to 2011, and he was elected president of the senate for 10 of those years. Shumlin served as the chair of the Democratic Governors Association during his first two terms.
During his time in office, Governor Shumlin established Vermont as a leader on progressive policies, making the state the first to guarantee universal pre-kindergarten education for all 3 and 4-year-old children, pass a mandatory GMO labeling law, and achieve near universal healthcare coverage with the lowest rate of uninsured in the country. Under his leadership, Vermont consistently ranked among the top states in solar energy jobs per capita and enacted a number of laws to boost renewable energy production and combat climate change. Because of Vermont’s leadership, Governor Shumlin was invited by President Obama to the Paris Climate Summit to push for a global climate agreement.
Governor Shumlin turned the nation’s eyes to the problem of opiate and heroin addiction by dedicating his entire 2014 State of the State Address to the issue and pushing for policies to treat addiction as the healthcare crisis that it is.
A committed entrepreneur, Shumlin is the longtime co-director of Putney Student Travel, National Geographic Student Expeditions, and Smithsonian Student Travel, sending high school age students on educational programs and service projects across the globe. He is a Director of The Scotts-MiracleGro Company, has served as a visiting fellow at the Harvard Kennedy School of Government, and has taught at the Harvard Chan School of Public Health as the Menschel Senior Leadership Fellow.
Rick SmithInvestor and Advisor
A pioneer of technology with the vision of making the bullet obsolete, Rick founded the original company, TASER, in 1993. As the TASER device became ubiquitous in law enforcement, Rick pushed the company beyond weapons technology and towards a broader purpose of matching technology to public safety needs in order to make the world a safer place. Under his leadership, the company has grown from a garage in Tucson to a NASDAQ-listed global market leader in conducted electrical weapons, body worn cameras and software. Rick was winner of the Ernst and Young 2002 Entrepreneur of the Year. Rick graduated from Harvard with a B.S. in Neuroscience (Cum Laude) and later earned a Master in International Finance from the University of Leuven in Belgium and an MBA from the University of Chicago.LinkedIn
John StrongHealthcare Supply Chain
In his role with ASPI, John works with medical device manufacturers and medical products and technology companies on strategic planning, sales, education, marketing, national accounts strategy and more.
John is a 40-year veteran of the healthcare industry, with leadership experience in healthcare providers, suppliers and service providers, and group purchasing organizations. In 2011 the Bellwether League (Health Care Supply Chain Hall of Fame) inducted John for “his outstanding contributions over the years to healthcare supply chain management, development, innovation and leadership."
John has developed and implemented programs that have generated hundreds of millions of dollars in value for his employers and clients. Prior to co-founding ASPI in 2018, John served as president of Greenhealth Management, a subsidiary of Practice Greenhealth. It operates Greenhealth Exchange, which is focused on developing specifications and aggregating green, sustainable purchasing volume to accelerate the adoption of better and more sustainable products in the healthcare industry. He also held executive leadership positions with Nexera, Inc. a wholly owned subsidiary of the Greater New York Hospital Association, where he was Senior Vice President of Management Services and served as the founding President and Chief Executive Officer of Consorta, a $5 billion-dollar group purchasing organization serving more than 350 hospitals.
He participated in the development of programs providing more than $500 million in value to Consorta’s owners during his more than ten-year tenure. John also served in a number of senior executive positions at Premier, Inc., where he was a key architect of Premier’s contracting programs, member service and marketing operations for the group purchasing program, increasing purchasing volume more than eight-fold.LinkedIn
Kwame UlmerFDA Regulatory Affairs
Mr. Ulmer led Regulatory Affairs and Quality Assurance for Danaher Corporation. Prior to that he spent 12 lears at the FDA, retiring as Deputy Director. He has reviewed over 1,000 new medical devices and technologies.
Kwame holds a Masters in Materials Engineering and a MBA from University of Virginia.LinkedIn
Jim WalkerInvestor and Advisor
Jim has more than 30 years of professional experience in Sales, Marketing, Sales Operations and National Accounts management in the medical device sector. His experience spans both domestic and international responsibilities, with a focus on strategic market development and key customer management.
In Jim’s 18-year tenure as a sales executive with Boston Scientific Corporation (BSC), he established the company as a recognized leader with Group Purchasing Organizations and created a world-class Corporate Sales organization that represented the full BSC portfolio to supply chain executives across every level of market aggregation, including Group Purchasing Organizations, National and Regional Integrated Delivery Networks, and National and Regional Purchasing Alliances. He was the lead strategic pricing advisor for the company and gained the support of the executive management team to invest in and develop an enterprise-wide contract management system that provides global pricing intelligence and profitability analysis capabilities.
Jim served on the company’s Operating Committee and advised BSC international executives on strategies for managing market globalization and the increasing focus on economic value. He also served on the GHX Board of Directors and on their European President’s Council through 2012.
Early in his career Jim had a successful tenure with Johnson & Johnson as Director of Sales of the Orthopedic Implant division and of the Hospital Services division. Prior to founding ASPI in 2018, Jim successfully represented numerous device companies with major U.S and Global customers and also consulted to SMI, an industry collaborative of major U.S. IDN Supply Chain Executives. Jim holds a B.S. in Education from Northeastern University.LinkedIn
Jim WeissInvestor and Advisor
Jim Weiss is the founder and chief executive officer of W2O, the leading independent provider of analytics-driven, digital-first marketing and communications to the healthcare sector.
Over the years, Jim has often been recognized as one of the most influential people in health communications and PR. Some of his many accolades include 500 Most Important People in the Global PR Industry (2015, 2017), PRWeek’s Power List (2012, 2013, 2014, 2019, 2020), Innovator of the Year (2020), Top 50 Health Influencer (2016, 2017, 2018, 2019) and Top 25 Innovator in Communications (2014). He was inducted into the Hall of Fame at the Newhouse School of Public Communications at Syracuse University, his alma mater, and honored as one of its 50Forward most accomplished graduates of the last 50 years.
Jim, with his wife Audra, founded the W2O Group Center for Social Commerce at the Newhouse School. Viewed as one of the most successful industry/academic partnerships, the Center provides students with modern media analytics and digital insight and skills to set them apart from their peers.
Inspired by a commitment to diversify the workforce, Jim partnered with Kim Hunter at The LAGRANT Foundation (TLF) to form the first-of-its-kind paid healthcare fellowship, which places multicultural minorities pursuing careers in healthcare communications in a W2O office. He sits on the TLF’s Board of Directors.
With 30 years of experience in strategic media and marketing communications in the healthcare and technology sectors, Jim has been involved in nearly every aspect of corporate, product and organizational communications. Before starting his own firm, he was head of corporate communications and investor relations at medical device start-up Heartport, a pioneer in minimally invasive cardiac surgery. Prior to that, he helped establish the global product marketing communications function at pharmaceutical giant Sanofi in Paris. He started his corporate career at biotechnology bellwether Genentech during its formative commercial years in the early 1990s.
Jim is on the Board of Trustees of the Cancer Research Institute and The Commons Project and is an Advisory Board member of the Newhouse School and the Healthcare Businesswomen’s Association.
Jim resides with his wife and two children in the San Francisco Bay Area, where W2O is headquartered.
Access Strategy Partners Inc (ASPI) aligns medical device companies with healthcare providers and supply chain organizations to simplify the acquisition of leading-edge technology.
The ASPI team has collectively spent decades building and leading corporate sales and contracting organizations for leading healthcare manufacturers and supply chain organizations, utilizing successful IDN and National Accounts strategic insights and relationships. ASPI brings deep expertise and experience in commercialization, supply chain, contract management & execution, value proposition optimization and well beyond.
ASPI leadership spent many years working for large device manufacturers and supply chain contracting organizations that could take advantage of broad product portfolios, large corporate contracts and other incentives that help drive the sales process. The result is an environment that can inhibit or at least slow innovation...innovation that can benefit patients, clinicians and healthcare providers. ASPI collaborates with companies with new technologies and a strong value equation, to better position them for successful market access by developing a strategy to enable them to become meaningful trading partners.
This is an industry of talented, compassionate people whom ASPI has enjoyed working with and building productive relationships. Our goal is to simplify the acquisition of leading-edge, value-based technology.
ASPI works with a select group of manufacturers, providing knowledgeable key account management representation and related services, to position them for successful market access with key providers and contracting organizations. For providers, this means we bring a portfolio of qualified, relevant suppliers from around the globe.